CD209 and neoplasm: In the tumor microenvironment, DC-SIGN (+) dendritic cells mediate efficient tumor-associated antigen presentation to T lymphocytes via ICAM-3, a DC-SIGN-binding protein that leads to the regression of established tumors [30–32].